Balyasny Asset Management L.P.

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1218710 Chicago, IL

Position in MIRM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$57,267,131

+$7,471,448 QoQ

Shares Held

489,170

-9.3% QoQ

Ownership

0.753%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#33

of 327 holders

Holding Since

Mar 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. MIRM ranks #10 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$57,267,131	489,170	-9.3%	Shares	Sole	2026-08-14
2026-03-31	$49,795,683	539,031	+88.6%	Shares	Sole	2026-05-15
2025-12-31	$22,580,871	285,870	-9.9%	Shares	Sole	2026-02-17
2025-09-30	$23,250,266	317,150	+1082.7%	Shares	Sole	2025-11-14
2025-03-31	$1,208,060	26,816	+43.1%	Shares	Sole	2025-05-15
2024-12-31	$774,609	18,733	+87.0%	Shares	Sole	2025-02-14
2024-03-31	$251,601	10,016	-44.7%	Shares	Sole	2024-05-13
2023-09-30	$572,181	18,107	+76.7%	Shares	Sole	2023-11-14
2023-03-31	$246,204	10,250	—	Shares	Other	2023-05-15
No filing history on record for this holder in this stock.